Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth
Solvonis Therapeutics plc (LSE: SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (‘CNS’) disorders, is...











